THE 1992 Convention on Biological Diversity (CBD) decrees that western pharmaceutical companies, long accustomed to freeloading rich flora of tropical countries, can no longer plunder that fabulous treasure without paying a suitable price to its rightful owner. But medicine monarchs of the world have found a chink in the CBD’s armour: botanical gardens, rich repositories of biodiversity from the South.